User profiles for Yuanchao Zhang
Yuanchao ZhangChildren's Hospital of Philadelphia Verified email at chop.edu Cited by 643 |
Abnormal topological organization of structural brain networks in schizophrenia
… Yuanchao Zhang and Lei Lin performed the network analyses. Yuanchao Zhang and Lei
Lin contributed technical expertise to cortical thickness analysis. Tung-Ping Su, Kun-Hsien …
Lin contributed technical expertise to cortical thickness analysis. Tung-Ping Su, Kun-Hsien …
[HTML][HTML] New gold nanostructures for sensor applications: a review
Y Zhang, W Chu, AD Foroushani, H Wang, D Li, J Liu… - Materials, 2014 - mdpi.com
Gold based structures such as nanoparticles (NPs) and nanowires (NWs) have widely been
used as building blocks for sensing devices in chemistry and biochemistry fields because of …
used as building blocks for sensing devices in chemistry and biochemistry fields because of …
[PDF][PDF] Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact
Spaceflight is known to impose changes on human physiology with unknown molecular
etiologies. To reveal these causes, we used a multi-omics, systems biology analytical approach …
etiologies. To reveal these causes, we used a multi-omics, systems biology analytical approach …
The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein
Y Zhang, LZ Benet - Clinical pharmacokinetics, 2001 - Springer
Intestinal phase I metabolism and active extrusion of absorbed drug have recently been
recognised as major determinants of oral bioavailability. Cytochrome P450 (CYP) 3A, the major …
recognised as major determinants of oral bioavailability. Cytochrome P450 (CYP) 3A, the major …
Role of P‐glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics
VJ Wacher, JA Silverman, Y Zhang… - Journal of …, 1998 - Wiley Online Library
Cytochrome P450 3A4 (CYP3A4), the major phase I drug metabolizing enzyme in humans,
and the MDR1 gene product P‐glycoprotein (P‐gp) are present at high concentrations in …
and the MDR1 gene product P‐glycoprotein (P‐gp) are present at high concentrations in …
Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral proteins bind to host
mitochondrial proteins, likely inhibiting oxidative phosphorylation (OXPHOS) and stimulating …
mitochondrial proteins, likely inhibiting oxidative phosphorylation (OXPHOS) and stimulating …
[HTML][HTML] Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease
Z Yao, Y Zhang, L Lin, Y Zhou, C Xu… - PLoS computational …, 2010 - journals.plos.org
Recently, many researchers have used graph theory to study the aberrant brain structures
in Alzheimer's disease (AD) and have made great progress. However, the characteristics of …
in Alzheimer's disease (AD) and have made great progress. However, the characteristics of …
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
LZ Benet, T Izumi, Y Zhang, JA Silverman… - Journal of controlled …, 1999 - Elsevier
Cytochrome P-450 3A4 (CYP3A4), the major phase I drug metabolizing enzyme in humans,
and the multidrug efflux pump, MDR or P-glycoprotein (P-gp), are present at high levels in …
and the multidrug efflux pump, MDR or P-glycoprotein (P-gp), are present at high levels in …
Predicting drug–drug interactions: an FDA perspective
L Zhang, Y Zhang, P Zhao, SM Huang - The AAPS journal, 2009 - Springer
Pharmacokinetic drug interactions can lead to serious adverse events, and the evaluation of
a new molecular entity’s drug–drug interaction potential is an integral part of drug …
a new molecular entity’s drug–drug interaction potential is an integral part of drug …
A regulatory viewpoint on transporter-based drug interactions
L Zhang, Y Zhang, JM Strong, KS Reynolds… - Xenobiotica, 2008 - Taylor & Francis
1. Pharmacokinetic drug interactions can lead to serious adverse events and the evaluation
of a new molecular entity's (NME) drug–drug interaction potential is an integral part of drug …
of a new molecular entity's (NME) drug–drug interaction potential is an integral part of drug …